Targeting VEGF could do more harm than good in the eye
Preclinical studies have raised a potential red flag on anti-VEGF therapies, suggesting that increasingly aggressive use in eye disease could trip...
New References Published
Innovative Research has had several new references in publications over the past week. Below are just a few of the...
Fate's tissue regeneration proteins validated in vivo
San Diego-based Fate Therapeutics, which focuses on the discovery and development of adult stem cell modulators, has announced that its...
